Correction: Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
Respiratory Research volume 24, Article number: 107 (2023)
Correction : Respiratory Research (2022) 23:291 https://doi.org/10.1186/s12931-022-02195-3
Following the publication of the original article , it was noted that the additional files 8, 9, and 10 were processed incorrectly due to miscommunication during the correction process. It has been corrected in this correction
The original article has been corrected.
Anan K, Kataoka Y, Ichikado K, Kawamura K, Johkoh T, Fujimoto K, Tobino K, Tachikawa R, Ito H, Nakamura T, Kishaba T, Inomata M, Kamitani T, Yamazaki H, Ogawa Y, Yamamoto Y. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respir Res. 2022;23:291. https://doi.org/10.1186/s12931-022-02195-3.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The RECORD statement—checklist of items, extended from the STROBE statement, that should be reported in observational studies using routinely collected health data.
Disease names adopted as inclusion criteria.
Disease names adopted as exclusion criteria.
About this article
Cite this article
Anan, K., Kataoka, Y., Ichikado, K. et al. Correction: Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis. Respir Res 24, 107 (2023). https://doi.org/10.1186/s12931-023-02411-8